Screener
NeoGenomics NEO Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred income tax liabilities, net | 16,824 | 18,219 |
| Other long-term liabilities | 862 | 12,042 |
| Total long-term liabilities | 460,628 | 434,968 |
| Total liabilities | $566,511 | $523,268 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity | ||
| Common stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively) | $130 | $129 |
| Treasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7) | (25,000) | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's total liabilities?
- NeoGenomics (NEO) reported total liabilities of $566.51M in Q2 2026.
- How has NeoGenomics's total liabilities changed year-over-year?
- NeoGenomics's total liabilities increased by 4.9% year-over-year, from $539.91M to $566.51M.
- What is the long-term trend for NeoGenomics's total liabilities?
- Over 5 years (2020 to 2025), NeoGenomics's total liabilities has grown at a 12.2% compound annual growth rate (CAGR), from $294.04M to $523.27M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about NeoGenomics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude